408
Participants
Start Date
June 12, 2020
Primary Completion Date
November 19, 2022
Study Completion Date
November 19, 2022
ARQ-154
ARQ-154 foam 0.3% applied once daily for 52 weeks
Arcutis Biotherapeutics Clinical Site 55, New York
Arcutis Biotherapeutics Clinical Site 63, The Bronx
Arcutis Biotherapeutics Clinical Site 27, Pittsburgh
Arcutis Biotherapeutics Clinical Site 28, Rockville
Arcutis Biotherapeutics Clinical Site 17, Norfolk
Arcutis Biotherapeutics Clinical Site 23, High Point
Arcutis Biotherapeutics Clinical Site 76, Charleston
Arcutis Biotherapeutics Clinical Site 65, Sanford
Arcutis Biotherapeutics Clinical Site 42, Coral Gables
Arcutis Biotherapeutics Clinical Site 24, Miami
Arcutis Biotherapeutics Clinical Site 53, Aventura
Arcutis Biotherapeutics Clinical Site 57, Delray Beach
Arcutis Biotherapeutics Clinical Site 12, Tampa
Arcutis Biotherapeutics Clinical Site 15, Louisville
Arcutis Biotherapeutics Clinical Site 18, Bexley
Arcutis Biotherapeutics Clinical Site 22, Plainfield
Arcutis Biotherapeutics Clinical Site 40, Clinton Township
Arcutis Biotherapeutics Clinical Site 58, Fort Gratiot
Arcutis Biotherapeutics Clinical Site 20, Detroit
Arcutis Biotherapeutics Clinical Site 14, Fridley
Arcutis Biotherapeutics Clinical Site 10, Rolling Meadows
Arcutis Biotherapeutics Clinical Site 52, Metairie
Arcutis Biotherapeutics Clinical Site 13, Arlington
Arcutis Biotherapeutics Clinical Site 25, Houston
Arcutis Biotherapeutics Clinical Site 41, College Station
Arcutis Biotherapeutics Clinical Site 54, San Antonio
Arcutis Biotherapeutics Clinical Site 26, Pflugerville
Arcutis Biotherapeutics Clinical Site 11, Austin
Arcutis Biotherapeutics Clinical Site 50, Las Vegas
Arcutis Biotherapeutics Clinical Site 62, Los Angeles
Arcutis Biotherapeutics Clinical Site 59, Beverly Hills
Arcutis Biotherapeutics Clinical Site 21, Santa Monica
Arcutis Biotherapeutics Clinical Site 51, Encino
Arcutis Biotherapeutics Clinical Site 64, San Diego
Arcutis Biotherapeutics Clinical Site 75, Fountain Valley
Arcutis Biotherapeutics Clinical Site 19, Fremont
Arcutis Biotherapeutics Clinical Site 29, Portland
Arcutis Biotherapeutics Clinical Site 73, Brighton
Arcutis Biotherapeutics Clinical Site 56, Portsmouth
Lead Sponsor
Arcutis Biotherapeutics, Inc.
INDUSTRY